Madrigal Pharmaceuticals, Inc. (MDGL)

523.69 -16.20 (-3.00%) USD  |  NASDAQ  |  May 15, 16:00
524.10 +0.41 (+0.08%) After-Hours: 20:00
More

Madrigal Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Insmed, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
PTC Therapeutics, Inc. Upgrade
Protagonist Therapeutics, Inc. Upgrade
Altimmune, Inc. Upgrade